MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Successful Treatment of Orthostatic Tremor using Perampanel

A. Wadhwa, S. Schaefer (New Haven, CT, USA)

Meeting: 2019 International Congress

Abstract Number: 229

Keywords: Orthostatic tremor (also see Tremors), Tremors: Treatment

Session Information

Date: Monday, September 23, 2019

Session Title: Clinical Trials, Pharmacology and Treatment

Session Time: 1:45pm-3:15pm

Location: Agora 3 West, Level 3

Objective: Orthostatic tremor is notoriously difficult to treat. To date, there has only been one case report of marked improvement of symptoms using perampanel. We present a case that redemonstrates similar findings using perampanel for the treatment of this condition.

Background: Orthostatic tremor continues to remain a therapeutic conundrum. Due to the rare nature of this disorder there have not been any well designed randomized controlled trials. Anecdotal evidence supports the use of various medication classes such as benzodiazepines, beta blockers and antiepileptic agents. However, results remain modest at best.

Method: A 62-year-old female with a 13 year history of primary orthostatic tremor, confirmed on EMG in the arms (while bracing against a desk) and legs (while standing) and refractory to clonazepam up to 20mg/day, was treated with perampanel 1mg/day with an additional 1mg/day as needed.

Results: She reported 90% subjective symptomatic improvement after using it for 4 months. She had no side effects. However, she did continue to have high frequency tremor on EMG in the quadriceps on standing, while reporting no tremor symptoms.

Conclusion: This case highlights the potential for use of a novel AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor antagonist for the treatment of primary orthostatic tremor. Perampanel is primarily used as an antiepileptic medication, at higher doses than we have used in this patient. It acts by blocking glutamate activity at the post-synaptic AMPA receptors. Side effects include significant psychiatric symptoms, for which every patient should be screened regularly. There has been one prior case report citing its use for orthostatic tremor with complete resolution of symptoms. Akin to the previously published report, the patient continued to have persistent tremor on EMG, pointing only towards a symptomatic benefit rather than one targeting the underlying etiology, which remains poorly understood. We encourage further studies to highlight its efficacy for orthostatic tremor.

References: [1] Ruiz-Julián M, Orozco JL, Gironell A. Complete Resolution of Symptoms of Primary Orthostatic Tremor with Perampanel. Tremor Other Hyperkinet Mov (N Y). 2018;8:552. Published 2018 Apr 17. doi:10.7916/D8QZ3SZD [2] Benito-León, J., & Domingo-Santos, Á. (2016). Orthostatic Tremor: An Update on a Rare Entity. Tremor and other hyperkinetic movements (New York, N.Y.), 6, 411. doi:10.7916/D81N81BT

To cite this abstract in AMA style:

A. Wadhwa, S. Schaefer. Successful Treatment of Orthostatic Tremor using Perampanel [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/successful-treatment-of-orthostatic-tremor-using-perampanel/. Accessed May 19, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/successful-treatment-of-orthostatic-tremor-using-perampanel/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley